Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable galactokinase GalK (galactose kinase) | 0.0053 | 0.565 | 1 |
Trypanosoma cruzi | galactokinase, putative | 0.0046 | 0.4593 | 0.813 |
Trypanosoma cruzi | galactokinase-like protein, putative | 0.0046 | 0.4593 | 0.813 |
Echinococcus granulosus | ribonuclease H1 | 0.0021 | 0.0839 | 0.1485 |
Brugia malayi | RNase H family protein | 0.0021 | 0.0839 | 0.6462 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.1122 | 0.1122 |
Brugia malayi | RNase H family protein | 0.0021 | 0.0839 | 0.6462 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0023 | 0.1122 | 0.1122 |
Echinococcus granulosus | N acetylgalactosamine kinase | 0.0024 | 0.1298 | 0.2298 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.0021 | 0.0839 | 0.5 |
Echinococcus multilocularis | galactokinase | 0.0053 | 0.565 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.1122 | 0.1122 |
Trichomonas vaginalis | galactokinase, putative | 0.0024 | 0.1298 | 1 |
Leishmania major | galactokinase-like protein | 0.0053 | 0.565 | 1 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0021 | 0.0839 | 0.1485 |
Brugia malayi | galactokinase family protein | 0.0024 | 0.1298 | 1 |
Echinococcus granulosus | galactokinase | 0.0053 | 0.565 | 1 |
Trypanosoma cruzi | galactokinase, putative | 0.0053 | 0.565 | 1 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0023 | 0.1122 | 0.1122 |
Schistosoma mansoni | phosphoglucomutase | 0.0021 | 0.0839 | 0.0839 |
Trypanosoma brucei | RNA helicase, putative | 0.0081 | 1 | 1 |
Echinococcus multilocularis | N acetylgalactosamine kinase | 0.0024 | 0.1298 | 0.2298 |
Toxoplasma gondii | GHMP kinase, N-terminal domain-containing protein | 0.0024 | 0.1298 | 1 |
Leishmania major | ribonuclease H1, putative | 0.0021 | 0.0839 | 0.1485 |
Toxoplasma gondii | ribonuclease HI protein | 0.0021 | 0.0839 | 0.6462 |
Giardia lamblia | Ribonuclease H | 0.0021 | 0.0839 | 1 |
Entamoeba histolytica | galactokinase, putative | 0.0053 | 0.565 | 0.5 |
Schistosoma mansoni | phosphoglucomutase | 0.0021 | 0.0839 | 0.0839 |
Trichomonas vaginalis | galactokinase, putative | 0.0024 | 0.1298 | 1 |
Brugia malayi | RNase H family protein | 0.0021 | 0.0839 | 0.6462 |
Echinococcus multilocularis | ribonuclease H1 | 0.0021 | 0.0839 | 0.1485 |
Trypanosoma brucei | ribonuclease H1 | 0.0021 | 0.0839 | 0.0839 |
Mycobacterium ulcerans | galactokinase | 0.0053 | 0.565 | 1 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0021 | 0.0839 | 1 |
Mycobacterium leprae | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0016 | 0 | 0.5 |
Schistosoma mansoni | galactokinase | 0.0024 | 0.1298 | 0.1298 |
Trypanosoma cruzi | galactokinase, putative | 0.0053 | 0.565 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.0021 | 0.0839 | 0.0839 |
Trichomonas vaginalis | galactokinase, putative | 0.0024 | 0.1298 | 1 |
Treponema pallidum | galactokinase | 0.0046 | 0.4593 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0021 | 0.0839 | 0.1826 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0023 | 0.1122 | 0.1122 |
Trichomonas vaginalis | galactokinase, putative | 0.0024 | 0.1298 | 1 |
Trypanosoma brucei | galactokinase-like protein, putative | 0.0035 | 0.2916 | 0.2916 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.0021 | 0.0839 | 0.1485 |
Loa Loa (eye worm) | galactokinase | 0.0024 | 0.1298 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 0.32 uM | In vitro anti-cancer activity against DU-145(Prostate) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.32 uM | In vitro anti-cancer activity against DU-145(Prostate) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.33 uM | In vitro anti-cancer activity against UACC 62(Melanoma) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.33 uM | In vitro anti-cancer activity against UACC 62(Melanoma) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.34 uM | In vitro anti-cancer activity against ACHN(Renal) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.34 uM | In vitro anti-cancer activity against ACHN(Renal) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.53 uM | In vitro anti-cancer activity against HOP 62(Lung) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.53 uM | In vitro anti-cancer activity against HOP 62(Lung) human tumor cell line | ChEMBL. | 10397491 |
GI50 (functional) | = 0.65 uM | In vitro anti-cancer activity against SF 268(CNS) human tumor cell lines | ChEMBL. | 10397491 |
GI50 (functional) | = 0.65 uM | In vitro anti-cancer activity against SF 268(CNS) human tumor cell lines | ChEMBL. | 10397491 |
GI50 (functional) | = 3.03 uM | In vitro anti-cancer activity against MCF-7/ADR(Breast) human tumor cell lines | ChEMBL. | 10397491 |
GI50 (functional) | = 3.03 uM | In vitro anti-cancer activity against MCF-7/ADR(Breast) human tumor cell lines | ChEMBL. | 10397491 |
GI50 (functional) | = 3.57 uM | In vitro anti-cancer activity against OVCAR 8(Ovarian) human tumor cell lines | ChEMBL. | 10397491 |
GI50 (functional) | = 3.57 uM | In vitro anti-cancer activity against OVCAR 8(Ovarian) human tumor cell lines | ChEMBL. | 10397491 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.